P. Dobroński

PROSPECTIVE EVALUATION OF PROSTATE CANCER DETECTED ON BIOPSIES 1, 2, 3 AND 4: WHEN SHOULD WE STOP?

Bob Djavan, V. Ravery, A. Zlotta et al. · The Journal of Urology · 2001 · 447 citations

SAFETY AND MORBIDITY OF FIRST AND REPEAT TRANSRECTAL ULTRASOUND GUIDED PROSTATE NEEDLE BIOPSIES: RESULTS OF A PROSPECTIVE EUROPEAN PROSTATE CANCER DETECTION STUDY

Bob Djavan, Matthias Waldert, Alexandre R. Zlotta et al. · The Journal of Urology · 2001 · 349 citations

Complexed prostate-specific antigen, complexed prostate-specific antigen density of total and transition zone, complexed/total prostate-specific antigen ratio, free-to-total prostate-specific antigen ratio, density of total and transition zone prostate-specific antigen: results of the prospective multicenter European trial

Bob Djavan, Mesut Remzi, Alexandre R. Zlotta et al. · Urology · 2002 · 114 citations

Urology, Benign Prostatic Hyperplasia, Biostatistics +4

Characteristics of Patients Presenting with LUTS/BPH in Six European Countries

Annie Hutchison, Richard Farmer, Christopher R. Chapple et al. · European Urology · 2006 · 68 citations

Clinical Disorders, Cardiovascular Disease, Psychiatry +5

Twenty years of experience with Krzeski’s cystovaginoplasty for vaginal agenesis in Mayer‐Rokitansky‐Küster–Hauser syndrome: anatomical, histological, cytological and functional results

M Czaplicki, P. Dobroński · British Journal of Urology · 2008 · 24 citations